US HB5745 | 2021-2022 | 117th Congress

Status

Spectrum: Partisan Bill (Republican 3-0)
Status: Introduced on October 27 2021 - 25% progression, died in committee
Action: 2021-10-27 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]

Summary

To clarify Medicare coverage for COVID-19 testing and to provide support for cellular immune response research for COVID-19, and for other purposes.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

COVID–19 Access to Testing and Support for Immune Response Research Act of 2021

Sponsors


History

DateChamberAction
2021-10-27HouseReferred to the Subcommittee on Health.
2021-10-27HouseReferred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2021-10-27HouseIntroduced in House

Subjects


US Congress State Sources


Bill Comments

feedback